Hawaii SCR 241: REQUESTING THE DEPARTMENT OF HEALTH TO CONVENE A MEDICINAL PSILOCYBIN WORKING GROUP TO EXAMINE THE MEDICINAL AND THERAPEUTIC EFFECTS OF PSILOCYBIN AND DEVELOP A LONGTERM STRATEGIC PLAN TO ENSURE THE AVAILABILITY OF MEDICINAL PSILOCYBIN OR PSILOCYBIN-BASED PRODUCTS THAT ARE SAFE, ACCESSIBLE, AND AFFORDABLE FOR ELIGIBLE ADULT PATIENTS.

Status: Referred to CPH. (as of 2020-03-10)

State: Hawaii · Session: 2020 Regular Session · Bill: SCR 241

Subjects: Medicinal Psilocybin Working Group, Department of Health

Sponsors: IHARA

View Hawaii SCR 241 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.